Skip to content

Clinical trials

Phase 1 Neoplasms trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 1 Country / region: Hong Kong Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20141
20171
20182
20191
20221
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting4
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
AstraZeneca1
Bayer1
Bio-Cancer Treatment International Limited1
Boehringer Ingelheim1
GlaxoSmithKline1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms13
Carcinoma, Non-Small-Cell Lung4
Colorectal Neoplasms3
Carcinoma, Hepatocellular2
Carcinoma, Renal Cell2
Head and Neck Neoplasms2
Kidney Neoplasms2
Pancreatic Neoplasms2
Adenocarcinoma, Clear Cell1
Anus Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.